Arnica gel for joint pain

The short version: arnica gel appears to reduce osteoarthritis pain about as well as a standard NSAID gel, with slightly fewer local side effects, but the evidence is thin, old, and mostly industry-independent.

The best study for your question is a 2007 randomized double-blind trial that compared arnica gel directly to ibuprofen gel in 204 people with hand osteoarthritis [1]. After 21 days, both groups improved by about the same amount: pain dropped by roughly 27 points on a 100-point scale with arnica and 24 points with ibuprofen. Hand function improved equally. The arnica group had slightly fewer adverse events (4.8% versus 6.1%), all mild skin reactions [1]. That trial was not funded by a manufacturer, which is a rare strength.

An older 2002 open-label trial in knee osteoarthritis reported significant improvements in pain, stiffness, and function on the WOMAC index, with 76% of patients saying they would use the gel again [2]. But open-label means no placebo group, so the improvement could be expectation or natural recovery. That design tells you little about real effectiveness.

The mechanism is plausible: arnica contains sesquiterpene lactones that reduce inflammation topically. But the evidence base is small. Only one decent randomized trial exists, it lasted just three weeks, and it tested hand osteoarthritis, not knee or back pain. No study has compared arnica gel to a true placebo in a rigorous design. The 2002 knee study is too weak to count.

My call: arnica gel is a reasonable first-line topical for hand osteoarthritis pain, about as effective as an NSAID gel with fewer skin reactions. But the evidence is limited to one short trial, and long-term safety data does not exist. Confidence: moderate for short-term pain relief, low for anything beyond three weeks.